BARRIE, Ontario, Jan. 09, 2020 (GLOBE NEWSWIRE) — MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) (“MediPharm Labs” or the “Company”) a global leader in research-driven, pharmaceutical quality...
Canadian licensed producers experienced their ninth consecutive monthly decline during December, with the Canadian Cannabis LP Index falling 2.8% to 393.78: The index remains substantially below the all-time closing high of...
MediPharm Labs Receives Licence Amendment to Permit Use of Expanded Canadian Facility for Private Label and White Label Production and R&D BARRIE, Ontario, Dec. 30, 2019 (GLOBE NEWSWIRE) —...
BARRIE, Ontario, Dec. 13, 2019 (GLOBE NEWSWIRE) — MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) (“MediPharm Labs” or the “Company”) a global leader in specialized research-driven cannabis...
BARRIE, Ontario, Dec. 06, 2019 (GLOBE NEWSWIRE) — MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) (“MediPharm Labs” or the “Company”) a global leader in specialized, research-driven cannabis...
Canadian licensed producers experienced another rough month in November, with the Canadian Cannabis LP Index falling 16.0% to 404.94, the eighth consecutive monthly loss: The index remains substantially below the all-time...
You’re reading a copy of this week’s edition of the free New Cannabis Ventures weekly newsletter, which we have been publishing since October 2015. Sign up to receive a copy...
Exclusive Interview with MediPharm Labs Co-Founder and President Keith Strachan MediPharm Labs (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ), focused solely on producing cannabis concentrates, has a leading revenue position...
The Public Cannabis Company Revenue & Income Tracker, managed by New Cannabis Ventures, ranks the top revenue producing cannabis stocks that generate industry sales of more than US$7.5 million per...
You’re reading a copy of this week’s edition of the free New Cannabis Ventures weekly newsletter, which we have been publishing since October 2015. Sign up to receive a copy...
MediPharm Labs Reports Strong, Profitable 2019 Third Quarter While Investing for Future Global Advantage Revenue $43.4 million, adjusted EBITDA $10.1 million BARRIE, Ontario, Nov. 12, 2019 (GLOBE NEWSWIRE) —...
BARRIE, Ontario, Nov. 05, 2019 (GLOBE NEWSWIRE) — MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) (the “Company”) a global leader in specialized, research-driven cannabis extraction, distillation and...
BARRIE, Ontario, Nov. 04, 2019 (GLOBE NEWSWIRE) — MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) (“MediPharm Labs” or the “Company”) a global leader in specialized, research-driven cannabis...
After a 57.4% gain in Q1, the Global Cannabis Stock Index moved sharply lower again in October, its seventh consecutive monthly decline, as it lost 11.2% to 47.29: The index,...
The Public Cannabis Company Revenue & Income Tracker, managed by New Cannabis Ventures, ranks the top revenue producing cannabis stocks that generate industry sales of more than US$7.5 million per...
BARRIE, Ontario, Oct. 31, 2019 (GLOBE NEWSWIRE) — MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) (“MediPharm Labs” or the “Company”) a global leader in specialized, research-driven cannabis...
BARRIE, Ontario, Oct. 25, 2019 (GLOBE NEWSWIRE) — MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) (“MediPharm Labs” or the “Company”) a global leader in specialized, research-driven cannabis...
Access to Applied Research Opportunities Donation of $100,000 of Cannabis Derivatives Towards Studies Hiring of Interns & Hosting Annual Cohort for Educational Lectures BARRIE, Ontario, Oct. 23, 2019 (GLOBE...
MediPharm Labs Enters New Beverages and Culinary Lifestyle Market Through Cannabis Concentrate Supply Partnership with Tea and Edibles Company Olli Brands Inc. TORONTO, Oct. 16, 2019 (GLOBE NEWSWIRE) —...
You’re reading a copy of this week’s edition of the free New Cannabis Ventures weekly newsletter, which we have been publishing since October 2015. Sign up to receive a copy...
TORONTO, Oct. 10, 2019 (GLOBE NEWSWIRE) — MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) (“MediPharm Labs” or the “Company”) a global leader in specialized, research-driven cannabis extraction,...
MediPharm Labs receives permits for additional Canadian exports of medical cannabis concentrate to Australia and completes related shipments Australian exports represent a 137% greater volume compared to first export...
You’re reading a copy of this week’s edition of the free New Cannabis Ventures weekly newsletter, which we have been publishing since October 2015. Sign up to receive a copy...
MediPharm Labs to supply TerrAscend with large volumes of high-quality CBD and THC distillate Multi-Year supply agreement to support TerrAscend’s roll out of Canadian Cannabis 2.0 derivative products TORONTO,...
MediPharm Labs Enters European Medical Cannabis Market with German Pharmaceutical and Medical Cannabis Distributor ADREXpharma® First extraction-only company with supply agreement for export to Germany Second international distribution milestone...
